chlorethylclonidine has been researched along with Brain Vascular Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johns, EJ; Sattar, MA | 1 |
1 other study(ies) available for chlorethylclonidine and Brain Vascular Disorders
| Article | Year |
|---|---|
Evidence for an alpha 1-adrenoceptor subtype mediating adrenergic vasoconstriction in Wistar normotensive and stroke-prone spontaneously hypertensive rat kidney.
Topics: Adrenergic alpha-Antagonists; Amlodipine; Animals; Cerebrovascular Disorders; Clonidine; Dose-Response Relationship, Drug; Electric Stimulation; Hypertension; Kidney; Male; Methoxamine; Phenylephrine; Piperazines; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Adrenergic, alpha-1; Renal Circulation; Sympathetic Nervous System; Vasoconstriction | 1994 |